HOME >> BIOLOGY >> NEWS
Severe Falciparum Malaria Increases In Honduras

Washington, Sept. 1, 1998--A dramatic increase has been reported in falciparum malaria in northern Honduras by a group of researchers writing in the current issue of the Pan American Journal of Public Health.

"Over the past few years there has been a striking increase in malaria in Honduras," the journal said. Reported cases rose from 52,110 in 1994 to 75,565 in 1996, a 45% increase in three years. The journal is published by the Pan American Health Organization.

Malaria is a significant cause of death and disease worldwide. Each year, malaria parasites infect between 300 and 500 million people and cause more than 2.7 million deaths. Plasmodium vivax is reported to be the infecting strain in some 98% of Honduran malaria cases, the journal said. "However, we recently documented a much higher proportionate increase of falciparum malaria in northern Honduras." This type of malaria is a much more severe form of the disease.

The authors, Carol J. Palmer and colleagues from the University of Miami School of Medicine and John F. Lindo of the University of the West Indies in Jamaica, said they investigated a recent outbreak in the Coln region, and tested residents of that area as well as the city of San Pedro Sula. They collected 202 blood samples and found that 47% were positive for malaria parasites. Plasmodium vivax, the milder form, was present in 79% of the infected rural patients and 100% of the infected city patients.

The more severe form, Plasmodium falciparum, was present in 21% of the rural patients, the journal said. In 1996, this form of malaria accounted for 3.5% of the malaria cases in that area.

Possible explanations include increased transmission by mosquitoes as a result of a long rainy season, an increase in the non-immune population, development of chloroquine resistance by Plasmodium falciparum parasites, and underdiagnosis, the authors said.

"The widespread development
'"/>

Contact: Daniel Epstein
epsteind@paho.org
(202) 974-3459
Pan American Health Organization
1-Sep-1998


Page: 1 2

Related biology news :

1. Severe depression associated with greater number of nerve cells in thalamus region of brain
2. Severe kidney disease in blacks linked to genes on two chromosomes
3. Severe Pain Following Shingles Safely Relieved In Clinical Trial Of Anti-Convulsant Drug Gabapentin
4. Scientists Find Gene For Severe Form Of Epilepsy
5. Common Anti-Viral Medication Prevents Severe Eye Herpes
6. Common Food Dye Can Cause Severe Allergic Reactions
7. Oral Vaccine Protects Infants From Severe Rotavirus Diarrhea
8. GenVec, U.S. NMRC, and PATHs Malaria Vaccine Initiative partner to expand malaria vaccine efforts
9. Malaria rise in Africa parallels warming trends
10. Pan-African Malaria Conference November 17-22 in Arusha, Tanzania
11. Multilateral Initiative on Malaria Secretariat to move to Sweden

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Severe Falciparum Malaria Increases Honduras

(Date:8/5/2015)... According to a new market ... Services, Vertical (BFSI, Airport, IT & Telecom, Utilities, Education, ... to 2020", published by MarketsandMarkets, defines and segments the ... segments. The global PIAM Market is estimated to grow ... 2019, at a CAGR of 14.9 % from 2014 ...
(Date:8/5/2015)... , Aug. 5, 2015 The biosensors ... growth in applications, penetration into newer sectors, and development ... The global biosensors space has seen the entry of ... market so far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ... Sullivan, Analysis of the Global Biosensors Market ...
(Date:8/4/2015)... AMRI ) today reported financial and operating results for the ... Second quarter contract revenue of $ 85.2 ... contract margins of 26 % , Second ... EPS from royalties in the current quarter , ... very pleased to present another strong financial quarter, with all our ...
Breaking Biology News(10 mins):Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24
(Date:8/31/2015)... , Aug. 31, 2015  RXi Pharmaceuticals Corporation ... on discovering and developing innovative therapies primarily in ... that the 30-day review period following the filing ... ocular indications with the U.S. Food and Drug ... now active. Logo -  ...
(Date:8/31/2015)... Trimb Healthcare AB ("Trimb") today announced that it has ... a Dutch OTC company with operations in key European ... 16 million, with solid growth and leading brands in ... build a leading international OTC company, and this acquisition ... us a stronger North European OTC platform, from which ...
(Date:8/30/2015)... England , August 31, 2015 ... Wartezeit   einer Frau   für chirurgische   Behandlung ... Alter von 7-90   werden für eine   ... soll 1200 Frauen behandeln und die Anzahl ausgebildeter Chirurgen ... Astellas gab heute bekannt, dass  Action on ...
(Date:8/28/2015)... Aug. 28, 2015 /PRNewswire/ - RepliCel Life Sciences ... medicine company focused on the development of autologous ... quarter ended June 30, 2015, corporate highlights, and ... report are available at www.sedar.com ,  ... "RepliCel expects to launch its RCS-01 ...
Breaking Biology Technology:RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 2Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 3Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 4Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 5RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5
Cached News: